Figure 1

Figure 1

Download figure
Open in new tab
Download powerpoint

Figure 1

Patient disposition. *Two patients in the placebo treatment group received CZP and are included in the 200 mg group for safety evaluations. CZP, certolizumab pegol; ITT, intention-to-treat; MTX, methotrexate.

Vol 83 Issue 5 Table of Contents

Annals of the Rheumatic Diseases: 83 (5)

We will not keep your email address; we ask for it so your friend knows the email isn't spam.

Your email: *

Your name: *

Send to: *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Figure 1

Message subject: (Your Name) has forwarded a page to you from Annals of the Rheumatic Diseases

Message body: (Your Name) thought you would like to see this page from the Annals of the Rheumatic Diseases web site.

Your personal message:

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Alerts

You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.

User Name *

Password *

Email *

Citation Tools

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Figure 1

Annals of the Rheumatic Diseases

Cite This

APA
Chicago
Endnote
MLA

(). Figure 1. Annals of the Rheumatic Diseases, (), . Accessed April 19, 2024. Retrieved from http://ard.bmj.com/content/68/6/797/F1.

Download Powerpoint

Save to my folders

User Name *

Password *

Remember my user name & password.

Share this article

Click the icon of the social media platform on which you would like to share this article.

Share This Article:

Email this article to a friend

We will not keep your email address; we ask for it so your friend knows the email isn't spam.

Your email: *

Your name: *

Send to: *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Figure 1

Message subject: (Your Name) has forwarded a page to you from Annals of the Rheumatic Diseases

Message body: (Your Name) thought you would like to see this page from the Annals of the Rheumatic Diseases web site.

Your personal message:

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Respond to this article

Add to Selected Citations

View Selected Citations (0)